- Home
- ADXN vs MYSE Comparison
ADXN vs MYSE Comparison
Compare ADXN & MYSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- MYSE
- Stock Information
- Founded
- ADXN 2002
- MYSE 2014
- Country
- ADXN Switzerland
- MYSE United States
- Employees
- ADXN N/A
- MYSE N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- MYSE Telecommunications Equipment
- Sector
- ADXN Health Care
- MYSE Telecommunications
- Exchange
- ADXN Nasdaq
- MYSE Nasdaq
- Market Cap
- ADXN 8.0M
- MYSE 9.4M
- IPO Year
- ADXN N/A
- MYSE 2021
- Fundamental
- Price
- ADXN $8.73
- MYSE $2.06
- Analyst Decision
- ADXN Strong Buy
- MYSE
- Analyst Count
- ADXN 1
- MYSE 0
- Target Price
- ADXN $30.00
- MYSE N/A
- AVG Volume (30 Days)
- ADXN 1.0K
- MYSE 102.0K
- Earning Date
- ADXN 09-01-2025
- MYSE 08-14-2025
- Dividend Yield
- ADXN N/A
- MYSE N/A
- EPS Growth
- ADXN N/A
- MYSE N/A
- EPS
- ADXN 0.10
- MYSE N/A
- Revenue
- ADXN $278,508.00
- MYSE $315.00
- Revenue This Year
- ADXN $86.57
- MYSE N/A
- Revenue Next Year
- ADXN N/A
- MYSE N/A
- P/E Ratio
- ADXN $0.72
- MYSE N/A
- Revenue Growth
- ADXN N/A
- MYSE N/A
- 52 Week Low
- ADXN $6.51
- MYSE $1.11
- 52 Week High
- ADXN $13.27
- MYSE $9.34
- Technical
- Relative Strength Index (RSI)
- ADXN 58.21
- MYSE N/A
- Support Level
- ADXN $7.51
- MYSE N/A
- Resistance Level
- ADXN $8.21
- MYSE N/A
- Average True Range (ATR)
- ADXN 0.17
- MYSE 0.00
- MACD
- ADXN 0.11
- MYSE 0.00
- Stochastic Oscillator
- ADXN 100.00
- MYSE 0.00
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.